Growth Metrics

Nuwellis (NUWE) Accumulated Expenses (2011 - 2026)

Nuwellis posted quarterly Accumulated Expenses of $852000.0 for Q1 2026, up 23.66% year-on-year from $689000.0 in Q1 2025, and up 85.22% on a QoQ basis from $460000.0 in Q4 2025.

Nuwellis (NUWE) has 16 years of Accumulated Expenses data on file, last reported at $852000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 23.66% year-over-year to $852000.0; the trailing twelve-month figure through Mar 2026 stood at $852000.0 (up 23.66% YoY), and the FY2025 full-year result was $460000.0, down 28.12% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $852000.0, up from $460000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.2 million in Q4 2022 and bottomed at $460000.0 in Q4 2025.
  • The 5-year median for Accumulated Expenses is $725000.0 (2024), against an average of $983823.5.
  • The widest annual swing landed in 2022, when Accumulated Expenses advanced 29.87%; it then plunged 75.71% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $2.2 million in 2022, then slumped by 75.71% to $525000.0 in 2023, then climbed by 21.9% to $640000.0 in 2024, then fell by 28.12% to $460000.0 in 2025, then soared by 85.22% to $852000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $852000.0 (Q1 2026), $460000.0 (Q4 2025), and $523000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 852,000.00
Dec 31, 2025 460,000.00
Sep 30, 2025 523,000.00
Jun 30, 2025 561,000.00
Mar 31, 2025 689,000.00
Dec 31, 2024 640,000.00
Sep 30, 2024 597,000.00
Jun 30, 2024 706,000.00
Mar 31, 2024 725,000.00
Dec 31, 2023 525,000.00
Sep 30, 2023 1.02 Mn
Jun 30, 2023 1.23 Mn
Mar 31, 2023 1.31 Mn
Dec 31, 2022 2.16 Mn
Sep 30, 2022 1.75 Mn
Jun 30, 2022 1.63 Mn
Mar 31, 2022 1.34 Mn
Dec 31, 2021 1.66 Mn
Sep 30, 2021 1.77 Mn
Jun 30, 2021 1.58 Mn
Mar 31, 2021 1.25 Mn
Dec 31, 2020 2.19 Mn
Sep 30, 2020 2.01 Mn
Jun 30, 2020 1.70 Mn
Mar 31, 2020 1.11 Mn
Dec 31, 2019 1.59 Mn
Sep 30, 2019 1.24 Mn
Jun 30, 2019 1.19 Mn
Mar 31, 2019 831,000.00
Dec 31, 2018 1.50 Mn
Sep 30, 2018 1.32 Mn
Jun 30, 2018 979,000.00
Mar 31, 2018 650,000.00
Dec 31, 2017 1.02 Mn
Sep 30, 2017 815,000.00
Jun 30, 2017 644,000.00
Mar 31, 2017 868,000.00
Dec 31, 2016 909,000.00
Sep 30, 2016 629,000.00
Jun 30, 2016 954,000.00
Mar 31, 2016 555,000.00
Dec 31, 2015 1.37 Mn
Sep 30, 2015 856,000.00
Jun 30, 2015 1.24 Mn
Mar 31, 2015 741,000.00
Dec 31, 2014 1.08 Mn
Sep 30, 2014 917,000.00
Jun 30, 2014 757,000.00
Mar 31, 2014 637,000.00
Dec 31, 2013 1.32 Mn
Sep 30, 2013 910,000.00
Jun 30, 2013 926,000.00
Mar 31, 2013 435,000.00
Dec 31, 2012 931,000.00
Sep 30, 2012 681,000.00
Jun 30, 2012 619,000.00
Mar 31, 2012 402,000.00
Dec 31, 2011 978,000.00